Skip to content

Roche abandon Biojector 2000 for T-20 administration

Decline in mortality rate amongst people with HIV has slowed in recent years

Anti-HIV treatment, weight and low income risk factors for heart disease

Pain control out of reach for 100 million worldwide

HIV-positive patients who aren't tested for HCV have an increased risk of death

Urinary stones a rare side-effect of atazanavir

Return of nelfinavir's European license recommended

ICAAC: High mortality rate from symptomatic lactic acidosis in Thailand

ICAAC: Hardening of the arteries found in one in five patients in Swiss HIV cohort